2015
DOI: 10.1681/asn.2015030231
|View full text |Cite
|
Sign up to set email alerts
|

2-Deoxy-d-Glucose Ameliorates PKD Progression

Abstract: Autosomal dominant polycystic kidney disease (ADPKD) is an important cause of ESRD for which there exists no approved therapy in the United States. Defective glucose metabolism has been identified as a feature of ADPKD, and inhibition of glycolysis using glucose analogs ameliorates aggressive PKD in preclinical models. Here, we investigated the effects of chronic treatment with low doses of the glucose analog 2-deoxy-D-glucose (2DG) on ADPKD progression in orthologous and slowly progressive murine models creat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

9
138
1
2

Year Published

2017
2017
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 158 publications
(150 citation statements)
references
References 30 publications
9
138
1
2
Order By: Relevance
“…5 A and B). The mice showed no visible side effects upon treatment with 2-DG, which is in line with previous observations describing the safe use of the substance in various animal models and humans even at much higher doses than used in the present study (30)(31)(32)(33)(34). Therefore, 2-DG induced "metabolic starvation" of RVs, which might be considered as a strategy to combat this widespread pathogen.…”
Section: -Dg Reverts Rv-induced Reprogramming Of Host Cell Metabolismsupporting
confidence: 93%
“…5 A and B). The mice showed no visible side effects upon treatment with 2-DG, which is in line with previous observations describing the safe use of the substance in various animal models and humans even at much higher doses than used in the present study (30)(31)(32)(33)(34). Therefore, 2-DG induced "metabolic starvation" of RVs, which might be considered as a strategy to combat this widespread pathogen.…”
Section: -Dg Reverts Rv-induced Reprogramming Of Host Cell Metabolismsupporting
confidence: 93%
“…2DG, an inhibitor of glycolysis, has shown some efficacy in controlling cystogenesis in rapidly progressing Ksp‐Cre ; Pkd1 flox/– and Pkd1 V/V mouse models for polycystic kidney disease (9, 45). 2DG and glycolysis have no known link to control of ciliation, raising the possibility that the combination of ganetespib with 2DG might result in a synergistic effect that is based on orthogonal action.…”
Section: Resultsmentioning
confidence: 99%
“…Recently, some new evidences indicate fundamental difference between cyst epithelial cells and normal epithelial cells in their energy metabolism. Additionally, energy metabolism alteration can promote cell proliferation and cyst expansion in PKD (Chiaravalli et al, ).…”
Section: Warburg Effect Accelerates Cyst Expansion In Pkdmentioning
confidence: 99%